InMode (INMD) Gross Margin (2018 - 2026)

InMode (INMD) posted Gross Margin of 75.05% for Q1 2026, down 4.13% sequentially from 78.28% in Q4 2025, and down 317.0% YoY from 34.58% in Q1 2025.

InMode (INMD) Gross Margin (2018 - 2026) Analysis & Trends

InMode has reported Gross Margin for 9 years, with the latest figure at 75.05% in Q1 2026.

Quarterly Gross Margin fell 317.0% year-over-year to 75.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 77.84% (down 220.0% YoY) and the FY2025 annual result came in at 78.54%, down 177.0% from the prior year.
Gross Margin eased to 75.05% in Q1 2026 per INMD's latest filing, from 78.28% in the prior quarter.
Over five years, Gross Margin peaked at 84.52% in Q3 2022 and troughed at 75.05% in Q1 2026.
A 5-year average of 81.14% and a median of 81.53% in 2024 frame the typical range for Gross Margin.
The sharpest annual moves came in 2023 and 2024: Gross Margin surged 88 bps in 2023, then sank 468 bps in 2024.
Over 5 years, Gross Margin stood at 84.28% in 2022, then decreased by 0 bps to 84.02% in 2023, then fell by 6 bps to 79.34% in 2024, then retreated by 1 bps to 78.28% in 2025, then slipped by 4 bps to 75.05% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 75.05%, 78.28%, and 77.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	57.71%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	68.27%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	65.35%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	77.46%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	47.38%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	45.84%
10	InMode	912.51 Mn	497.35 Mn	71.52 Mn	74.82%

Download Data